Study day | Average antigen ODa | Average mf/mlc | ||
---|---|---|---|---|
Pre-heat treatment | Post-heat treatment | |||
−8 | ||||
Control | 0.25 ± 0.11 | 0.93 ± 0.39 | 18,383.3 ± 4776.8 | |
Fluralaner | 0.18 ± 0.12 | 0.78 ± 0.07 | 20,215.0 ± 3.530.4 | |
1 | ||||
Control | NAb | NAb | NAb | |
Fluralaner | NAb | NAb | NAb | |
29 | ||||
Control | 0.22 ± 0.12 | 0.70 ± 0.11 | 23,306.7 ± 6595.3 | |
Fluralaner | 0.32 ± 0.12 | 0.65 ± 0.07 | 18,512.5 ± 14,032.8 | |
55 | ||||
Control | 0.15 ± 0.04 | 0.76 ± 0.05 | 30,606.7 ± 10,717.2 | |
Fluralaner | 0.18 ± 0.10 | 0.71 ± 0.14 | 30,285.0 ± 18,255.8 | |
83 | ||||
Control | 0.33 ± 0.10 | 0.92 ± 0.07 | 32,410.0 ± 20,933.2 | |
Fluralaner | 0.44 ± 0.15 | 0.93 ± 0.03 | 21,750.0 ± 13,970.6 |